To address potential interferences from the HCT116 cellular background affecting the behavior of the BCL2 TMD mutants, we investigated the homo- and hetero-oligomerization of BCL2 TMD with BAX TMD in the HeLa cervix adenocarcinoma cell line. This evidence concerns the gene BCL2 and cervical adenocarcinoma.